EX-99.3 6 exhibit993investorpresen.htm EX-99.3 INVESTOR PRESENTATION exhibit993investorpresen
OCTOBER 31, 2023 INVESTOR UPDATE Exhibit 99.3


 
2 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Certain statements in this presentation may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or the future financial or operating performance of Benson Hill Inc. (the “Company” or “Benson Hill”) and may be identified by words such as “may,” “should,” “expect,” “intend,” “will,” “estimate,” “anticipate,” “believe,” “predict,” or similar words. These forward-looking statements are based upon assumptions made by the Company as of the date hereof and are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements include, among other things, statements regarding the Company’s current business model and go-to-market strategy and plans to transition that business model and go-to-market strategy, and the anticipated benefits, challenges, and potential timeline associated with such transition; statements regarding management’s strategy and plans for growth; statements regarding the Company’s plans to improve the Company’s capital structure and liquidity position, including by divesting its processing assets, reducing operating and capital expenses, and paying off its debt, and the anticipated timeline to achieve such objectives; projections of market opportunity and statements regarding potential market capture; statements regarding planned sources and uses of cash; statements regarding projected CAPEX, OPEX, and working capital; statements regarding the Company’s liquidity improvement plans and other cost-saving measures, actions to implement such plans, and the anticipated benefits of such plans; the Company’s ability to identify and evaluate its strategic alternatives and effect potential strategic opportunities in ways that maximize shareholder value; expectations regarding the Company’s ability to continue as a going concern; statements regarding the Company’s current expectations and assumptions regarding the industries and markets in which it currently and may operate, and macro-economic trends; statements regarding the traits and benefits of the Company’s current product pipeline and anticipated product portfolio; statements regarding anticipated acreage needs, and the benefits from and costs of acreage growth; anticipated benefits of the Company’s existing and potential future strategic partnerships and licensing strategies; the Company’s plans to achieve profitability and potential timeline therefor; expectations regarding sources of consolidated revenue and gross profit, and expectations for gross margin growth, including with respect to current and new product categories, such as animal feed; the Company’s positioning, resources, capabilities, and expectations for future performance; the projected environmental impact and sustainability of the Company’s operations; and projections of consumer preferences, industry trends and market opportunity, including with respect to the animal feed market. Factors that may cause actual results to differ materially from current expectations include, but are not limited to, risks associated with the Company’s transition of its business model and go- to-market strategy, its liquidity improvement plans and other cost saving measures; the risk that the Company’s may be unable to successfully implement its plans relating to its business model and go-to-market transition, and liquidity improvement plans and other cost saving measures, or that, even if such transition and plans are successfully implemented, such plans may be insufficient to achieve the objectives of such plans, or that there may be adverse impacts on the Company’s business and prospects from such plans; liquidity and other risks relating to the Company’s ability to continue as a going concern; risks associated with the Company’s ability to grow and achieve growth profitably, including continued access to the capital resources necessary for growth and to implement its transition and other plans in a timely manner; the risk that the Company will be unable to service, renegotiate or retire any of its existing debt, or to maintain compliance with applicable debt covenants; the risk that the Company’s actions intended to achieve profitability are insufficient; risks associated with the successfully developing new products and commercializing the Company’s product pipeline, entry into new markets and expansion of current markets; risks relating to potential dilution; the risk that the Company will not complete, or realize the anticipated benefits of, the divestiture of its processing assets; risks associated with managing capital resources; risks associated with financial forecasts; risks associated with maintaining relationships with customers and suppliers and developing and maintaining partnership and licensing relationships; risks associated with changing industry and market conditions and consumer preferences; risks associated with the Company’s ability to generally execute on its business strategy; risks associated with the effects of global and regional economic, agricultural, financial and commodities markets; the effectiveness of the Company’s risk management strategies; and other risks and uncertainties set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in our filings with the SEC, which are available on the SEC’s website at www.sec.gov. There may be additional risks about which the Company is presently unaware or that the Company currently believes are immaterial that could also cause actual results to differ materially from those contained in the forward-looking statements. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Nothing in this presentation should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward looking statements will be achieved. The Company expressly disclaims any duty to update these forward-looking statements, except as otherwise required by law. Disclaimers


 
BENSON HILL HAS A LOT TO BE PROUD OF. . . A multi-year moat around those protein traits, underpinned by distinctive germplasm and CropOS® platform Proven protein traits… which other players value and want (seed partners) Early proof of ability to successfully partner with players across the value chain Highly talented and engaged team with decades of valuable industry experience A compelling sustainability story delivering more protein per acre with the same inputs BUT ACHIEVING THE VISION IS GOING TO REQUIRE MEANINGFUL CHANGE. . . Accelerated expansion into animal feed presents significant opportunity for value creation Partners / new routes to markets are needed to reach new end markets, achieve scale, and manage parts of the process where Benson Hill is disadvantaged With the current innovation pipeline already in place, it will take time to achieve the acre ramp-up necessary to supply these massive new markets 3 Strong foundation in place for the next phase of Benson Hill’s evolution


 
Key messages today: Good progress made toward strengthening our balance sheet Giving us the time and space needed for business model transition Resulting in an extended but sustainable path to profitability 4


 
Key messages today: 5 Good progress made toward strengthening our balance sheet • Reductions in OPEX/CAPEX achieved • Sale of assets in process • Enabling elimination of debt Giving us the time and space needed for business model transition Resulting in an extended but sustainable path to profitability


 
• Delivering $33M run rate Opex savings for 2024, versus $20M target announced in March • Identifying additional Opex run rate savings ($5-10M) and aligning Capex (savings of $10-15M) to new asset-light model SHAPE THE BUSINESS - FIT FOR PURPOSE 1 6 Liquidity Improvement Actions


 
• Signed agreement to close the sale of the Seymour, Indiana, soy crush facility for approximately $36M in gross proceeds, subject to working capital and other adjustments • Exploring options to divest the remaining manufacturing assets • Divestitures expected to significantly lower working capital requirements to help extend liq uidity DIVEST ASSETS TO BUILD LIQUIDITY 2 Liquidity Improvement Actions 7


 
8 • Targeting early retirement of current senior term loan • Evaluating other alternative non-dilutive and equity sources of capital • Providing 12 months+ of liquidity runway Gross Cash Position: $50M - $80M Retirement of Senior Debt: ($121M) Total Cash: $170M - $200M Uses of CashSources of Cash Planned Planned RETIRE DEBT AND FUND THE BUSINESS 3 Liquidity Improvement Actions


 
Key messages today: 9 Good progress made toward strengthening our balance sheet Giving us the time and space needed for business model transition • Focusing on our core technology assets • Accelerating focus on animal feed • Building a less capital-intensive business Resulting in an extended but sustainable path to profitability


 
At its core, Benson Hill is a leader in AI driven seed innovation utilizing proprietary genetics Proprietary protein, genomic, and strategic data layers for predictive breeding using Artificial Intelligence (AI) and Machine Learning (ML) World-leading eMerge soy and proprietary yellow-pea protein germplasm Acquired 2019 Launched 2016 Launched 2021 Indoor year-round speed breeding and rapid prototyping facility …resulting in a complete and market leading toolbox to deliver seed innovations of the future. 10


 
11 End marketsCharacteristicsProduct Category Pet Food Consumer Packaged Goods Increased Protein Consumer Package Goods Food Services Animal Feed Lower Anti-nutrients High Oleic Low Linoleic Low Linolenic Consumer Package Goods Food Services High Oleic Low Linoleic Low Linolenic Animal FeedIncreased Protein Lower Anti-nutrients Improved Amino Acids Consumer Package GoodsUltra-high Protein COVAL HOLL UHP-LO (low oligosaccharide) UHP SO Y PR O TE IN Customer Value Proposition Heart healthy oil and functional benefits (oil stability) Improved digestibility, higher energy diet, more complete amino acid profile Heart healthy oil, improved digestibility Improved nutrition Cleaner Label Reduced Cost (Processing Yield Improvement) Improved nutrition Cleaner Label Reduced Cost (Processing Yield Improvement) Consumer Package Goods Same as UHP HP YE LL O W P EA 5 innovation platforms expected to drive growth across all market segments


 
12 2023 2024 2025 2026 2027 2028 2029 BENSON HILL’S TECHNOLOGY PIPELINE GEN1: 59-61% Meal Protein, Low- Antinutrients, AAs GEN2: >62% Meal Protein, Higher Yield GEN1.1: + HT GEN2.1: +HT GEN3: Higher Yield GEN1: 61-63% White Flake Protein GEN2: Higher Yield GEN1.1: + HT GEN2.1: +HT GEN3: >64% White Flake Protein GEN3.1: +HT GEN1: High-Oleic Oil, Better Carbohydrate GEN1.1: + HT GEN2: > 60% Meal Protein GEN2.1: +HT GEN3: >62% Meal Protein, Higher Yield Prototype: 60% Pea Protein Concentrate (PPC) GEN1:60% PPC GEN1.1: Higher Yield GEN1 GEN2 GEN3 COVAL & HOLL UHP-LO (low oligosaccharide) UHP SO Y PR O TE IN HP YE LL O W P EA And our pipeline is designed to stay ahead of the competition


 
13 Benson Hill is taking proactive action to retire debt, ensure liquidity, and extend runway…These measures will fully fund the business for 24-36 months Product-market fit / value proposition Poultry - Broiler Poultry - Layer Turkey Swine - Grower Swine - Nursery Aqua Pet SPC - Meat extension Soy Flour ISP - Alt. meat ISP - Sports / nutrition High oleic oil Biofuels1 NEW STRATEGIC PRIORITIESEXISTING MARKETS AND ADDITIONAL OPPORTUNITIES Market attractiveness SECONDARY OPPORTUNITIES ~28M ~5M Total addressable US acres in new strategic priorities Additional addressable acres in secondary opportunities Relative TAM, 2030 M acres 1. Scaled down for illustration purpose Animal Oil Human ISP=Isolate Soy Protein; SPC=Soy Protein Concentrate Source: USDA, FAOSTAT, Industry reports, Expert interviews, Press search Our innovation portfolio provides a compelling value proposition to expand our footprint into the largest soy protein markets


 
14 * UHP-LO’s value proposition is particularly pronounced for mono-gastric animals (not ruminants) including turkey, chicken, and swine UHP-LO is a game-changer for animal producers and ready today Source: Expert Interviews, UHP-LO trials with animal producers Reduced cost of feed – less soybean meal required to meet nutritional requirements Low oligosaccharide content* (Oligosaccharides are sugars that are hard to break down during digestion) Improved energy density of soybean meal by replacing undigestible sugars with sucrose Improved digestibility of feed – especially for development of young animals Improved amino acid profile (Part of trait pipeline) Higher relative share of critical amino acids for growth – reducing dependence on synthetic additives ~20% higher protein content Reduces animal producer total formula costs - Demand is real, and UHP-LO is uniquely advantaged TAM - U.S. Soybean acres in poultry and swine28M ACRES Current UHP-LO output traits exceed nearest competitor targets Trait 2023 UHP-LO 2027 UHP-LO Projected Increased Protein Content ~20% 20-25% Enhanced Amino Acids ✔ ✔ Reduced Anti-Nutritionals (Low Oligosaccharides - Raffinose, Stachyose) <0.5% <0.5% Yield (% commodity) 93% ~97% Herbicide Tolerance (HT) Non-GMO HT Specialty protein with enhanced amino acids target Achieving greater than 10% increase protein content. Increased Methionine, reduced anti-nutritionals. — Corteva Agriscience R&D Innovation update – May 9, 2023 The companies expect to commercialize these soybean varieties by late this decade. — Corteva Agriscience and Bunge – March 9, 2022 ”“ 1 2 INNOVATION PLATFORM EXAMPLE


 
15 Business model transition necessary R&D & Licensing Seed Production & GTM Grain Origination Processing Go-to-Market Current Closed- Loop Model Future Licensing Model Why Closed-loop is unsustainable for Benson Hill • Alt meat growth trajectory flattened, and grower acquisition costs increased • Existing assets require investment to deliver value-add food ingredient streams • High working capital requirements with underwhelming returns Rationale for move to a Licensing model • Partner grower networks are necessary to efficiently scale acreage • Investments need to be focused on core R&D • Capital efficiency Closed-loop model catalyzed demand for innovation, but is not sustainable going forward R&D & Licensing Seed Production & GTM Grain Origination Processing Go-to-Market


 
16 Benson Hill Seed Company VALUE CHAIN: Processors End-Markets Technology Access Fees Earn technology access fees from seed companies, processors and end-users Licensing Royalties License germplasm to seed companies to enable broadacre adoption Direct Seed Sales Grow direct seed sales through Benson Hill and eMerge brands Growers End market value creation: $100-230 per acre1 Opportunities to monetize our technology within the future licensing model 1. Value creation varies by end market; In animal feed in particular, value creation varies by species (e.g., Turkey vs. Broiler) and type of feed/diet (e.g., Grower vs. Nursery) Source: USDA, FAOSTAT, Industry reports, Expert interviews, Press search 1. 2. 3.


 
17 2.0 0.5 1.0 1.5 3.5 4.0 2.5 3.0 4.5 5.0 5.5 6.0 6.5 7.0 2024 2025 2026 2027 2028 2029 2030 Licensing parter for animal feed1 Licensing partner for food ingredients BH direct sale for food ingedients BH direct sale for animal feed Commercial piloting in turkey and “all-veg” chicken “Inflection point” and commercial launch for broilers & layers 1. Includes aquaculture and pet food Introduction of herbicide tolerance <20% <20% 20% 30% 50% 60% 70% Share of revenue from animal feed New licensing model expected to unlock growth through broadacre access Peak ramp-up UHP-LO US Acres (M) for Domestic Consumption Accessed by Benson Hill Technology U S Ac re s f or D om es tic C on su m pt io n (M ) Acre adoption outlook for Benson Hill genetics to enter animal feed


 
18 Benson Hill’s obtainable acres long term End market value creation per acre 6.5M acres $100-230 per acre3 1. Includes US end markets for broilers, layers, turkey, swine, salmon, pet food, human ingredients, and high-oleic oil 2. E.g., based on share of production under consolidated, commercial-scale processing and animal systems 3. Value creation varies by end market; In animal feed in particular, value creation varies by species (e.g., Turkey vs. Broiler) and type of feed/diet (e.g., Grower vs. Nursery) Source: USDA, FAOSTAT, Industry reports, Expert interviews, Press search Potential total market value created long-term $0.7-1.5 billion Value of Benson Hill genetics in the US soy market for domestic consumption Accessing only a share of serviceable acres could create total long-term value


 
19 1.25 1.26 1.28 1.42 1.56 2023 1.20 24 2725 26 1.25 2028 1.30 1.35 1.40 1.45 1.50 1.55 1.60 1.47 +14% +22% +16% Protein / acre (tons) Source: Product performance and pipeline forecast data 2022-2028 accounting for both protein content and agronomic yield 1 Assumes 0.6% yield improvement per annum On Farm: More protein per acre with equivalent inputs, land use and carbon emissions Commodity1 UHP-LO MORE PROTEIN PER ACRE Lower carbon intensity per unit of protein Less pressure on land per unit of protein Less pressure on water and inputs per unit of protein Processing: Higher protein content with the same manufacturing capabilities Customers Increased nutrition density UHP-LOIllustrative example for UHP-LO = Our sustainability impact is even more compelling within animal feed Benson Hill soybeans deliver impressive protein efficiency through nutrition density


 
Key messages today: Good progress made toward strengthening our balance sheet Giving us the time and space needed for business model transition Resulting in an extended but sustainable path to profitability 20


 
21 Phase 1: Vertically integrated food protein ingredients company Phase 2: Execute implementation of liquidity plan and launch go-to-market transition ​ Phase 3: ​ License seed technology & partner across value chain Phase 4: Expand Trait development and licensing Seed production & distribution Grain trading & processing Expected Gross Margin End markets Food ingredients Aqua Turkey Poultry Swine High oleic oil Biofuel Pet food <10% <10% Processing assets owned and operated Production contracted directly Processing assets sold and downstream processor partnerships established Production contracted directly Downstream processor partners responsible for contracting, processing, and ingredient sales Downstream processor partners responsible for contracting, processing, and ingredient sales Co-development and commercialization of Next-gen Varieties Seed produced and sold directly Licensing partnerships established Seed produced and sold directly R&D Next-gen seed traitsHerbicide tolerance and yield convergence Focus on high-value specialty traits (protein, high-oleic oil, LO, etc.) Focus on holistic value proposition (balance of protein, yield, oil, etc.) 30-80% >80% 2021-23 2024 2025-28 2029+PRELIMINARY Co-development and commercialization of Next-gen Varieties Transformation roadmap to shift to a licensing model


 
22 Liquidity Improvement actions enable efficient cash utilization * Subject to the timing of facility sales and excludes one-time costs in 2023 $102M $92M - $97M $55M - $60M (includes ~$10M in annual public company costs) Cash OPEX + CAPEX 2022 2023 2024 $64M $60M - $65M $35M - $40MNet Working Capital*


 
23 Closing comments: We have strengthened our balance sheet and are creating the liquidity runway to transition our business We have accelerated our evolution to serve the animal feed market and will continue to draw on our core differentiators – our people and our technology We are engaged in discussions to identify the right partners to take our business to the next level


 
APPENDIX 24


 
25 More attractive Less attractiveOverall assessment of market Market attractiveness (current) Product-market fit1 2 Animal feed Human ingredients Oil 1 2 4 3 5 6 7 8 9 10 11 12 Poultry - Broiler Poultry - Layer Poultry - Turkey Swine Aquaculture Pet SPC – Alt meat/meat extension Soy flour (textured/untextured) ISP – Alternative meat ISP – Sports/nutrition High-oleic cooking oil Biofuel Category End market 2030 TAM, M acres Growth / tailwinds Competition / substitution Relative complexity Fit with customer needs Today 2028 Opportunity for differentiation ~13.5 ~2.5 ~1.5 ~10.2 ~1.2 ~1.7 ~0.3 ~0.2 ~0.15 ~0.1 ~2 >50 Source: USDA, FAOSTAT, Industry reports, Expert interviews, Press search Expanding to animal feed is an immediate strategic priority Overview of market assessment of shortlisted end markets


 
26 • 2012 | Schillinger genetics partnered academic studies to determine energy value add for low oligosaccharide traits • 2020 | Feed trials with using Benson Hill High Protein and Quality Protein varieties to demonstrate reduced feed costs while maintaining animal health • 2023 | Shadow pricing studies with consultant to determine the value add of Benson Hill varieties for animal feed applications (broilers, layers, swine) Value add assumptions are based on academic studies, industry feed trials, and consultant driven pricing models


 
27 Academic study with Schillinger genetics germplasm shows an increase in energy density for low oligosaccharide varieties


 
28 Benson Hill performed a feeding study with poultry producer in 2020 that demonstrated lower feed costs and equivalent animal outcomes